Skip to main content

Table 1 Baseline characteristics of the participants

From: Effect of insomnia in the major depressive disorder

 

Slight

Moderate

Severe

P-value

Participants

16

21

18

 

Age (years)

35.16 ± 11.81

39.33 ± 10.95

39.83 ± 11.85

0.43

Gender (M/F)

7/9

8/13

6/12

0.82

Education

   

0.96

 Below 9 years, n (%)

1 (6.25)

2 (9.5)

1 (5.5)

 

 Up to 9 years, n (%)

5 (31.3)

7 (33.3)

8 (44.4)

 

 10–12 years, n (%)

3 (18.8)

2 (9.5)

2 (11.1)

 

 13–17 years, n (%)

7 (43.8)

10 (47.6)

7 (38.9)

 

Smoking, n (%)

2 (12.5)

3 (14.3)

3 (16.7)

0.94

First-episode, n (%)

10 (62.5)

13 (61.9)

9 (50)

0.69

Baseline HAMD score

21.94 ± 4.60

22.09 ± 5.04

22.94 ± 8.16

0.88

Baseline SCL 90 score

200.31 ± 53.69

205.38 ± 70.08

219.56 ± 67.57

0.72

Baseline ISI score

10.31 ± 2.94

16.81 ± 1.50

23.56 ± 1.62

 

Current treatment

   

0.78

 Sertraline

5

7

5

 

 Fluvoxamine

6

4

4

 

 Escitalopram

2

5

6

 

 Fluoxetine

3

5

3

 
  1. HAMD Hamilton Depression Scale, ISI Insomnia Severity Index, SCL-90 Symptom Checklist-90